Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
NCT00030069 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2016-01-15
Summary
This is a study to determine the response rate in patients with myelodysplastic syndromes treated with calcitriol and dexamethasone.
Conditions
Interventions
- DRUG
-
Calcitriol
- DRUG
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Primary Completion
- 2007-09-30
- Completion
- 2009-05-31
Countries
- United States
Study Locations
More Related Trials
-
Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
NCT00986804 ·Status: COMPLETED ·Phase: PHASE1
-
Amifostine in Treating Patients With Myelodysplastic Syndrome
NCT00003048 ·Status: COMPLETED ·Phase: PHASE2
-
Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes
NCT00398047 ·Status: TERMINATED ·Phase: PHASE2
-
Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
NCT00671697 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent
NCT03045510 ·Status: UNKNOWN ·Phase: PHASE2
-
Iadademstat With Hypomethylating Agent in Patients With Myelodysplastic Syndrome
NCT06502145 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients
NCT01333449 ·Status: TERMINATED ·Phase: PHASE2
-
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
NCT04802161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
NCT00006240 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)
NCT07006025 ·Status: RECRUITING ·Phase: PHASE1
-
Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk
NCT01720225 ·Status: COMPLETED ·Phase: PHASE2
-
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)
NCT01222195 ·Status: TERMINATED ·Phase: PHASE2
-
Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure
NCT01133886 ·Status: UNKNOWN ·Phase: PHASE2
-
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
NCT01806116 ·Status: UNKNOWN ·Phase: PHASE4
-
Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome
NCT00968071 ·Status: COMPLETED ·Phase: PHASE2
-
Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
NCT01362140 ·Status: COMPLETED ·Phase: PHASE3
-
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
NCT02121418 ·Status: COMPLETED ·Phase: NA
-
Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT02029950 ·Status: COMPLETED ·Phase: PHASE1
-
Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS
NCT03564873 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
NCT00234143 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes
NCT04985656 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
NCT06109064 ·Status: RECRUITING ·Phase: PHASE2
-
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
NCT00075725 ·Status: COMPLETED ·Phase: PHASE3
-
Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
NCT00043381 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT01005758 ·Status: UNKNOWN ·Phase: PHASE2